TY  - JOUR
AU  - Gutiérrez-Rojas, Luis
AU  - Sánchez-Alonso, Sergio
AU  - García Dorado, Marta
AU  - López Rengel, Paola M
PY  - 2022
DO  - 10.1007/s40263-022-00917-1
UR  - http://hdl.handle.net/10668/21641
T2  - CNS drugs
AB  - Treatment of schizophrenia requires long-term medication to prevent relapse. Treatment nonadherence may increase the risk of relapse, leading to increased hospitalizations and emergency room (ER) visits. Long-acting injectables (LAIs) such as...
LA  - en
KW  - Adult
KW  - Antipsychotic Agents
KW  - Aripiprazole
KW  - Delayed-Action Preparations
KW  - Humans
KW  - Paliperidone Palmitate
KW  - Recurrence
KW  - Retrospective Studies
KW  - Schizophrenia
KW  - Spain
TI  - Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain.
TY  - research article
VL  - 36
ER  -